PITTSBURGH, May 8 /PRNewswire/ -- Biocontrol Technology, Inc. (Nasdaq: BICO) announced today that its subsidiary, IDT, Inc., in conjunction with HemoCleanse, Inc. of West Lafayette, Indiana, has been given approval by the Food and Drug Administration (FDA) for two sites to conduct upcoming expanded ...